This past January, Medical University of South Carolina (MUSC) Hollings Cancer Center named Shikhar Mehrotra, PhD, co-leader of the Cancer Biology and Immunology research program. He is also a professor of surgery and the Cecilia and Vincent Peng Endowed Chair in melanoma and cutaneous oncology.
Dr. Mehrotra will serve in the role alongside Philip Howe, PhD, professor and chair of the Department of Biochemistry & Molecular Biology, and Sophie Paczesny, MD, PhD, professor in the Department of Microbiology & Immunology.
The role falls under the Cancer Biology and Immunology (CBI) research program, which combined the Cancer Biology program and the Cancer Immunology program. Dr. Mehrotra said he looks forward to continuing to mesh the two disciplines together through his work. He also hopes to make projects more translational to patients by driving more collaborative and holistic projects.
“I will undoubtedly play that role during presentations and one-on-one meetings with CBI program members to see what can be done to advance their projects and improve their immunological understanding,” Dr. Mehrotra said. “This will not only help advance knowledge on how any of the approaches are engaging the immune system but also give us a more robust argument when we bring them to the clinics.”
Source: MUSC, January 17, 2024.
